Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access ... were also "priced at a 50% or greater discount compared to the list price of all ...

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition from ...

Eli Lilly (NYSE ... popular weight loss therapy Zepbound (tirzepatide) at $499 through its direct-to-consumer website, LillyDirect. That indicates nearly a 23% discount to the price charged ...

Novo Nordisk’s new offering follows a model that Eli Lilly launched last year, offering vials of its weight-loss drug Zepbound at a discount directly to consumers paying cash. Last week ...

Medicare beneficiaries are also not eligible for Eli Lilly's savings card programs for Zepbound. Jonsson said "in an ideal world," the Trump administration will enact a proposed rule from the ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly ... a significant discount, but there's a catch: they can't use their health insurance. Last summer, Lilly started selling ...